Abiomed
ABMD
#1109
Rank
NZ$29.31 B
Marketcap
$650.06
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Net assets

Net assets on the balance sheet as of September 2022 : NZ$2.62 Billion

According to Abiomed's latest financial reports the company has NZ$2.62 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Abiomed - Net assets on balance sheet (from 2013 to 2022)

Net assets by year

Year Net assets Change
2022-03-31$NZ$2.15 B13.41%
2021-03-31$NZ$1.90 B7.26%
2020-03-31$NZ$1.77 B28.72%
2019-03-31$NZ$1.37 B44.63%
2018-03-31$NZ$0.95 B47.54%
2017-03-31$NZ$0.64 B20.83%
2016-03-31$NZ$0.53 B37.44%
2015-03-31$NZ$0.38 B100.15%
2014-03-31$NZ$0.19 B18.6%
2013-03-31$NZ$0.16 B6.42%
2012-03-31$NZ$0.15 B11.94%
2011-03-31$NZ$0.13 B-9.99%
2010-03-31$NZ$0.15 B-26.25%
2009-03-31$NZ$0.20 B73.64%
2008-03-31$NZ$0.11 B-30.12%
2007-03-31$NZ$0.17 B50.75%
2006-03-31$NZ$0.11 B43.55%
2005-03-31$NZ$78.84 M-3.25%
2004-03-31$NZ$81.49 M-27.32%
2003-03-31$NZ$0.11 B-37.7%
2002-03-31$NZ$0.17 B-34.23%
2001-03-31$NZ$0.27 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$7.64 B 191.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$35.75 B 1,260.96%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.79 B-69.80%๐Ÿ‡บ๐Ÿ‡ธ USA